A planned buyout of Life Technologies Corp. by Thermo Fisher Scientific Inc. for a proposed $13.6 billion is facing a financial hourglass as the companies expect a lengthy regulatory review process from international antitrust watchdogs, particularly in China. According to reports, the companies are now expecting that approval of the deal may not come until January 2014; if it is not closed by January 14, 2014, the price of the merger will increase by .6 cents per share every day. Analysts have noted that international regulators, especially the Ministry of Commerce in China, may hold up the deal, as the regulator is notorious for long-lasting review processes. Experts also note that determining potential competitive overlap that may result from the deal is difficult to determine. The deal primarily intends for the California-based Life Technologies to make Thermo, based in Massachusetts, the largest manufacturer of scientific and laboratory equipment in the world.
Full Content: The Deal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
ConocoPhillips Acquires Marathon Oil for $22.5 Billion in Major Energy Sector Consolidation
May 29, 2024 by
CPI
Judge Denies Amazon’s Bid to Dismiss FTC Lawsuit Over Prime Membership Practices
May 29, 2024 by
CPI
Germany and France Advocate for Major EU Competition Reform
May 29, 2024 by
CPI
Equifax Accused of Monopolizing Employment Verification Market in New Suit
May 29, 2024 by
CPI
Car Battery Makers to Challenge EU Cartel Charges in Brussels
May 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Merger Guidelines Retrospective
May 21, 2024 by
CPI
Mergers of Complements
May 21, 2024 by
CPI
Personality Traits, Private Equity, and Merger Analysis
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Lessons in the Importance of Incipiency, Modern Economics, and Monopsony
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Sharpening Merger Analysis
May 21, 2024 by
CPI